ÂÜÀòÂÒÂ×

Akash Patnaik is an experienced finance professional currently serving as Corporate Controller at CymaBay Therapeutics, a clinical-stage biopharmaceutical company, since May 2021. Prior to this role, Akash worked at Intarcia Therapeutics, Inc. from October 2019 to September 2021 as Controller and Finance Executive, managing the financial close process and providing technical accounting leadership. From January 2007 to September 2019, Akash was a Senior Director at PwC, where responsibilities included accounting, auditing, and advising clients on US GAAP and SEC matters for various multinational companies in the Pharma, Biotech, and Med Device sectors. Akash holds certifications from the American Institute of Certified Public Accountants and the Institute of Chartered Accountants of India and earned an MBA from Western Governors University.